Anti-Thrombotic Therapy Following Transcatheter Structural Heart Intervention
Journal of Clinical Medicine · 21.04.2026 · 15 (8) · 3175
DOI: 10.3390/jcm15083175 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 21.04.2026. Verfasst von Francesco Tartaglia und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, 20072 Milan, Italy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Transcatheter structural heart interventions, including aortic, mitral and tricuspid valve replacement or repair, and patent foramen ovale, atrial septal defect, and left atrial appendage closure, have dramatically expanded over the past two decades, providing substantial improvements in both clinical outcomes and quality of life. These interventions are performed in a high-risk patient population, which is at risk for both thrombotic and bleeding complications. The introduction of prosthetic devices into the arterial or venous circulation under heterogeneous hemodynamic conditions inevitably increases the risk for thrombotic events and thromboembolic complications. Consequently, the selection of antithrombotic therapy (AT) regimen and its duration is complex and should be tailored to each patient’s risk profile, balancing the expected risk and benefits. This state-of-the-art review critically examines the thrombotic risks inherent to transcatheter structural heart interventions, synthesizes available evidence and current guidelines recommendations on antithrombotic management, and defines persisting gaps in knowledge while discussing the most relevant ongoing clinical trials.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, 20072 Milan, Italy.
- IRCCS Humanitas Research Hospital, Rozzano, 20089 Milan, Italy.
- The Heart Center, Rigshospitalet, Copenhagen University Hospital, 2100 Copenhagen, Denmark.
- Montefiore Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
ORCID-Profile: Giulia Antonelli, Antonio Mangieri, Giulio Stefanini
Zitieren
APA
Tartaglia, F., Antonelli, G., Gabrielli, A., Gitto, M., Khokhar, A. A., Soriente, F., Leone, P. P., Regazzoli, D., de Backer, O., Mangieri, A., & Stefanini, G. (2026). Anti-Thrombotic Therapy Following Transcatheter Structural Heart Intervention. Journal of Clinical Medicine, 15(8), 3175. https://doi.org/10.3390/jcm15083175
Vancouver
Tartaglia F, Antonelli G, Gabrielli A, Gitto M, Khokhar AA, Soriente F, et al. Anti-Thrombotic Therapy Following Transcatheter Structural Heart Intervention. Journal of Clinical Medicine. 2026;15(8):3175. doi:10.3390/jcm15083175
BibTeX
@article{Tartaglia2026,
author = {Tartaglia, Francesco and Antonelli, Giulia and Gabrielli, Alessandro and Gitto, Mauro and Khokhar, Arif A and Soriente, Francesca and Leone, Pier Pasquale and Regazzoli, Damiano and de Backer, Ole and Mangieri, Antonio and Stefanini, Giulio},
title = {Anti-Thrombotic Therapy Following Transcatheter Structural Heart Intervention},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {8},
pages = {3175},
doi = {10.3390/jcm15083175}
}
EUVIMED